Absence of basal ganglia amino acid neuron deficits in schizophrenia in three collections of brains

Schizophrenia Research

Volumn 31, Issue 2-3, 1998, Pages 167-175

  Simpson, M D C ^a   Slater, P ^a   Deakin, J F W ^a   Gottfries, C G ^b   Karlsson, I ^b   Grenfeldt, B ^b   Crow, T J ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Basal ganglia; GABA uptake; Glutamate uptake; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ASPARTIC ACID; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NIPECOTIC ACID; PHENCYCLIDINE; TENOCYCLIDINE;

4 AMINOBUTYRIC ACID UPTAKE; ADULT; AGED; ARTICLE; BASAL GANGLION; CAUDATE NUCLEUS; CELL LOSS; CONTROLLED STUDY; GLOBUS PALLIDUS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PUTAMEN; SCHIZOPHRENIA;

AGED; AMINO ACID TRANSPORT SYSTEM X-AG; ANALYSIS OF VARIANCE; ASPARTIC ACID; ATP-BINDING CASSETTE TRANSPORTERS; BASAL GANGLIA; BINDING SITES; CARRIER PROTEINS; CASE-CONTROL STUDIES; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NIPECOTIC ACIDS; ORGANIC ANION TRANSPORTERS; PHENCYCLIDINE; PROLINE; RADIOLIGAND ASSAY; SCHIZOPHRENIA; TRITIUM;

EID: 0032565596     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(98)00020-6     Document Type: Article

References (32)

1. Benes, F.M., McSparren, J., Bird, E.D., SanGiovanni, J.P., Vincent, S.L., 1991. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 48, 996-1001.
2. Carlsson, A., 1995. Neurocircuitries and neurotransmitter interactions in schizophrenia. Int. J. Clin. Psychopharmacol. 10, 21-28.
3. Crow, T.J., Owen, F., Cross, A.J., Lofthouse, R., Longden, A., 1978. Brain biochemistry in schizophrenia. Lancet i. 36-37.
4. Danbolt, N.C., 1994. The high affinity uptake system for excitatory amino acids in the brain. Prog. Neurobiol. 44, 377-396.
5. Deakin, J.F.W., Slater, P., Simpson, M.D.C., Gilchrist, A.C., Skan, W.J., Royston, M.C., Reynolds, G.P., Cross, A.J., 1989. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J. Neurochem. 52, 1781-1786.
6. Deakin, J.F.W., Simpson, M.D.C., Slater, P., Hellewell, J.S.E., 1997. Familial and developmental abnormalities of frontal lobe function and neurochemistry in schizophrenia. J. Psychopharmacol. 11, 133-142.
7. Delfs, J.M., Anegawa, N.J., Chesselet, M.F., 1995. Glutamate decarboxylase messenger RNA in rat pallidum: comparison of the effects of haloperidol, clozapine and combined haloperidol-scopolamine treatments. Neuroscience 66, 67-80.
8. Feighner, J.P., Robins, E., Guzes, S.P., Woodruff, R.A., Winokur, E., Munoz, R.J., 1972. Diagnostic criteria for use in psychiatric research. Arch. Gen. Psychiatry 26, 57-63.
9. Fitzgerald, L.W., Deutch, A.Y., Gasic, G., Heinemann, S.F., Nestler, E.J., 1995. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J. Neurosci. 15, 2453-2461.
10. Fonnum, F., 1975. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24, 407-409.
11. Garbutt, J.C., van Kammen, D.P., 1983. The interaction between GABA and dopamine: implications for schizophrenia. Schizophr. Bull. 9, 336-353.
12. Hansson, L.O., Waters, N., Winblad, B., Gottfries, C.G., Carlsson, A., 1994. Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissue. J. Neural. Trans. 98, 217-235.
13. Harrison, P.J., 1995. On the neuropathology of schizophrenia and its dementia: neurodevelopmenlal. neurodegenerative. or both? Neurodegeneration 4, 1-12.
14. Johnson, A.E., Liminga, U., Liden, A., Lindefors, N., Gunne, L.M., Wiesel, F.A., 1994. Chronic treatment with a classical neuroleptic alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain. Neuroscience 63, 1003-1020.
15. Kendell, R.E., 1975. What are our criteria for a diagnosis of schizophrenia? In: van Praag, H.M. (Ed.). On the Origin of Schizophrenic Psychoses. De Erven Bohn, Amsterdam, pp. 125-137.
16. Kim, J.S., Kornhuber, H.H., Schmid-Burgk, W., Holzmuller, B., 1980. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20, 379-382.
17. 3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients. J. Neural. Trans. 77, 231-236.
18. Lindelfors, N., Brene, S., Herrera-Marschitz, M., Persson, H., 1989. Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain. Exp. Brain Res. 77, 611-620.
19. Lindefors, N., 1993. Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review. Prog. Neuropsychopharmacol. Biol. Psychiatry 17, 887-903.
20. Lloyd, K.G., Vargas, F., 1982. Nipecotic acid: identification of GABA uptake sites in frozen tissue. In: Okada, Y., Roberts, E. (Eds.), Problems in GABA Research. Excerpta Medica, Amsterdam, pp. 355-365.
21. Meshul, C.K., Bunker, G.L., Mason, J.N., Allen, C., Janowsky, A., 1996. Effects of subchronic clozapine and haloperidol on striutal glutamatergic synapses. J. Neurochem. 67, 1965-1973.
22. Reynolds, G.P., 1989. Beyond the dopamine hypothesis. The neurochemical pathology of schizophrenia. Br. J. Psychiatry 155, 305-316.
23. Reynolds, G.P., Czudek, C., Andrews, H.B., 1990. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol. Psychiatry 27, 1038-1044.
24. Riva, M.A., Tascedda, F., Lovati, E., Racagni, G., 1997. Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs. Mol. Brain Res. 50, 136-142.
25. Roberts, E., 1972. A hypothesis suggesting that there is a defect in the GABA system in schizophrenia. Neurosci. Res. Prog. Bull. 10, 468-482.
26. Simpson, M.D.C., Cross, A.J., Slater, P., Deakin, J.F.W., 1988. Loss of cortical GABA uptake sites in Alzheimer's disease. J. Neural Trans. 71, 219-226.
27. Simpson, M.D.C., Slater, P., Deakin, J.F.W., Royston, M.C., Skan, W.J., 1989. Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci. Lett. 107, 211-215.
28. Simpson, M.D.C., Slater, P., Royston, M.C., Deakin, J.F.W., 1991. Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication. Schizophr. Res. 6, 41-48.
29. Simpson, M.D.C., Slater, P., Royston, M.C., Deakin, J.F.W., 1992. Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia. Psychiatry Res. 42, 273-282.
30. 1A receptors in ventral prefrontal cortex in schizophrenia. Biol. Psychiatry 39, 919-928.
31. Spokes, E.G., Garrett, N.J., Rossor, M.N., Iversen, L.L., 1980. Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects. J. Neurol. Sci. 48, 303-313.
32. Vincent, S.L., Adamec, E., Sorensen, I., Benes, F.M., 1994. The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex. Synapse 17, 26-35.